Analysts have been eager to weigh in on the Healthcare sector with new ratings on Endologix (ELGX) and Merit Medical Systems (MMSI).
Endologix (ELGX)
BTIG analyst Marie Thibault maintained a Buy rating on Endologix today and set a price target of $6.00. The company’s shares closed last Monday at $1.11, close to its 52-week low of $0.69.
According to TipRanks.com, Thibault is a 1-star analyst with an average return of -6.4% and a 12.5% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Varian Medical Systems, and Edwards Lifesciences.
Endologix has an analyst consensus of Moderate Buy, with a price target consensus of $6.00.
See today’s analyst top recommended stocks >>
Merit Medical Systems (MMSI)
Barrington analyst Michael Petusky maintained a Hold rating on Merit Medical Systems today. The company’s shares closed last Monday at $38.75.
According to TipRanks.com, Petusky is a 3-star analyst with an average return of 2.9% and a 50.5% success rate. Petusky covers the Healthcare sector, focusing on stocks such as Varian Medical Systems, Anika Therapeutics, and Lemaitre Vascular.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Merit Medical Systems with a $39.83 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
